Skip to main content

Articles

Page 11 of 60

  1. Strokes significantly impair quality of life and incur high economic and societal burdens. The triglyceride and glucose (TyG) index is a biochemical marker of insulin resistance (IR) and may have important val...

    Authors: Ying Yang, Xiangting Huang, Yuge Wang, Lin Leng, Jiapei Xu, Lei Feng, Shixie Jiang, Jiang Wang, Yanrong Yang, Gaofeng Pan, Bing Jiang, Yan Wang and Lan Chen
    Citation: Cardiovascular Diabetology 2023 22:2
    Content type: Review Published on:

  2. Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulant...

    Authors: Shu-Man Lin, Peter Pin-Sung Liu, Yu-Kang Tu, Edward Chia-Cheng Lai, Jih-I Yeh, Jin-Yi Hsu, Kashif M. Munir, Carol Chiung-Hui Peng, Huei-Kai Huang and Ching-Hui Loh
    Citation: Cardiovascular Diabetology 2023 22:1
    Content type: Research Published on:

  3. Patients with type 2-diabetes mellitus (T2D), are characterized by visceral and ectopic adipose tissue expansion, leading to systemic chronic low-grade inflammation. As visceral adiposity is associated with se...

    Authors: Etienne Charpentier, Alban Redheuil, Olivier Bourron, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Nadjia Kachenoura, Khaoula Bouazizi, Joe-Elie Salem, Guillaume Hekimian, Matthieu Kerneis, Zahir Amoura, Yves Allenbach, Stephane Hatem, Anne-Caroline Jeannin, Fabrizio Andreelli…
    Citation: Cardiovascular Diabetology 2022 21:294
    Content type: Research Published on:

  4. High-density lipoproteins (HDL) comprise particles of different size, density and composition and their vasoprotective functions may differ. Diabetes modifies the composition and function of HDL. We assessed a...

    Authors: Qiao Jin, Eric S. H. Lau, Andrea O. Luk, Claudia H. T. Tam, Risa Ozaki, Cadmon K. P. Lim, Hongjiang Wu, Elaine Y. K. Chow, Alice P. S. Kong, Heung Man Lee, Baoqi Fan, Alex C. W. Ng, Guozhi Jiang, Ka Fai Lee, Shing Chung Siu, Grace Hui…
    Citation: Cardiovascular Diabetology 2022 21:293
    Content type: Research Published on:

  6. High glycemic variability (GV) is a poor prognostic marker in cardiovascular diseases. We aimed to investigate the association of GV with all-cause mortality in patients with acute heart failure (HF).

    Authors: Kyeong-Hyeon Chun, Jaewon Oh, Chan Joo Lee, Jin Joo Park, Sang Eun Lee, Min-Seok Kim, Hyun-Jai Cho, Jin-Oh Choi, Hae-Young Lee, Kyung-Kuk Hwang, Kye Hun Kim, Byung-Su Yoo, Dong-Ju Choi, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim…
    Citation: Cardiovascular Diabetology 2022 21:291
    Content type: Research Published on:

  7. To evaluate the impact of stress hyperglycemia on the in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes.

    Authors: Yiling Zhou, Li Liu, Hongmei Huang, Nan Li, Jidong He, Heling Yao, Xiaochi Tang, Xiangyang Chen, Shengzhao Zhang, Qingyang Shi, Furong Qu, Si Wang, Miye Wang, Chi Shu, Yuping Zeng, Haoming Tian…
    Citation: Cardiovascular Diabetology 2022 21:290
    Content type: Research Published on:

  8. The mechanisms linking obesity to cardiovascular disease (CVD) are still not clearly defined. Individuals who are overweight or obese often develop insulin resistance, mediation of the association between obes...

    Authors: Xue Tian, Shuohua Chen, Penglian Wang, Qin Xu, Yijun Zhang, Yanxia Luo, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2022 21:289
    Content type: Research Published on:

  9. Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” techno...

    Authors: Hao Wang, Youxin Wang, Xingang Li, Xuan Deng, Yuanyuan Kong, Wei Wang and Yong Zhou
    Citation: Cardiovascular Diabetology 2022 21:288
    Content type: Research Published on:

  10. Non-alcoholic fatty liver disease (NAFLD) is a well-known risk factor for cardiovascular (CV) disease (CVD) and mortality. However, whether the progression or regression of NAFLD can increase or decrease the r...

    Authors: Jiyun Park, Gyuri Kim, Hasung Kim, Jungkuk Lee, Sang-Man Jin and Jae Hyeon Kim
    Citation: Cardiovascular Diabetology 2022 21:287
    Content type: Research Published on:

  11. Endothelium function is often impaired in patients with type 2 diabetes. We hypothesized that by improving endothelial function using diastole-synchronized compressions/decompressions (DSCD) to the lower body ...

    Authors: Paul Valensi, Nicolas Barber-Chamoux, Amel Rezki, Céline Lambert, Bruno Pereira, Christian Dualé, Dominique Delmas and Martine Duclos
    Citation: Cardiovascular Diabetology 2022 21:286
    Content type: Research Published on:

  12. The mechanism by which a sodium-glucose cotransporter inhibitor (SGLT2i) induces favorable effects on diabetes and cardiovascular diseases including heart failure (HF) remains poorly understood. Metabolomics i...

    Authors: Satoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, Ryohei Nagaoka, Ryo Numazawa, Kotaro Yamano, Yusuke Fujisawa, Katsuhiko Ohori, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Wataru Ohwada, Masaki Katayose, Tatsuya Sato, Atsushi Kuno and Masato Furuhashi
    Citation: Cardiovascular Diabetology 2022 21:285
    Content type: Research Published on:

  13. We hypothesize that early events of diabetes and cardiovascular disease continuums would be ongoing and associated in adolescents. We investigated the association between the Insulin Resistance Phenotype and the

    Authors: Janaina Maiana Abreu Barbosa, Antônio Augusto Moura da Silva, Rosangela Fernandes Lucena Batista, Bernadete Jorge Leal Salgado, Joelma Ximenes Prado Teixeira Nascimento, Vanda Maria Ferreira Simões, Maria Jacqueline Silva Ribeiro, Marco Antonio Barbieri, Alexandre Archanjo Ferraro and Cecilia Claudia Costa Ribeiro
    Citation: Cardiovascular Diabetology 2022 21:284
    Content type: Research Published on:

  14. Patients with type 2 diabetes mellitus (T2DM) usually have higher blood viscosity attributed to high blood glucose that can decrease blood supply to the pancreas. A mild increase in blood pressure (BP) has bee...

    Authors: Zhang Xia, Lijuan Song, Dongdong Fang, Wenjun You, Feng Li, Deqiang Zheng, Yuhao Li, Lu Lin, Jingtao Dou, Xin Su, Qi Zhai, Yingting Zuo, Yibo Zhang, Herbert Y. Gaisano, Jiajia Jiang and Yan He
    Citation: Cardiovascular Diabetology 2022 21:283
    Content type: Research Published on:

  15. The risk of severe coronavirus disease 2019 (COVID-19) is increased in people with diabetes, but effects of diabetes type and other risk factors remain incompletely characterized. We studied this in a Swedish ...

    Authors: Robin Kristófi, Johan Bodegard, Viveca Ritsinger, Marcus Thuresson, David Nathanson, Thomas Nyström, Anna Norhammar and Jan W. Eriksson
    Citation: Cardiovascular Diabetology 2022 21:282
    Content type: Research Published on:

  16. Time in range (TIR), a novel proxy measure of glucose control, is found closely related to diabetic microangiopathy and some other chronic complications, but the correlation between TIR and lower limb angiopat...

    Authors: Yinghua Wei, Chunyan Liu, Yanyu Liu, Zhen Zhang, Zhouqin Feng, Xinyi Yang, Juan Liu, Haiyan Lei, Hui Zhou, Qiuyue Shen, Bin Lu, Ping Gu and Jiaqing Shao
    Citation: Cardiovascular Diabetology 2022 21:281
    Content type: Research Published on:

  17. The triglyceride-glucose (TyG) index was significantly related to clinical outcome in patients with cardiovascular disease (CAD) and cerebrovascular disease (CVD). We aim to investigate the association between...

    Authors: Dong Liu, Kaixuan Yang, Hongqiu Gu, Zixiao Li, Yongjun Wang and Yilong Wang
    Citation: Cardiovascular Diabetology 2022 21:280
    Content type: Research Published on:

  18. We aimed to examine the impact of gender and specific type of cardiovascular disease (CVD) diagnosis (ischemic heart disease [IHD], heart failure, peripheral artery disease [PAD] or stroke) on time-to-initiati...

    Authors: Kristian Løkke Funck, Lasse Bjerg, Anders Aasted Isaksen, Annelli Sandbæk and Erik Lerkevang Grove
    Citation: Cardiovascular Diabetology 2022 21:279
    Content type: Research Published on:

  19. Subclinical LV dysfunction (LVD) identifies heart failure (HF) risk in type 2 diabetes mellitus (T2DM). We sought the extent to which clinical scores (ARIC-HF, WATCH-DM), natriuretic peptides (NTpBNP) and trop...

    Authors: Amera Halabi, Elizabeth Potter, Hilda Yang, Leah Wright, Julian W. Sacre, Jonathan E. Shaw and Thomas H. Marwick
    Citation: Cardiovascular Diabetology 2022 21:278
    Content type: Research Published on:

  20. A substantial proportion of type 1 diabetes (T1D) patients free from known cardiovascular disease (CVD) show premature arterial stiffening, with age, blood pressure, and HbA1c—as gold standard of glycemic cont...

    Authors: Simon Helleputte, Patrick Calders, Arthur Rodenbach, Joke Marlier, Charlotte Verroken, Tine De Backer and Bruno Lapauw
    Citation: Cardiovascular Diabetology 2022 21:277
    Content type: Research Published on:

  21. Coronary heart disease (CHD) and type 2 diabetes (T2D) are two complex diseases with complex interrelationships. However, the genetic architecture of the two diseases is often studied independently by the indi...

    Authors: Han Xiao, Yujia Ma, Zechen Zhou, Xiaoyi Li, Kexin Ding, Yiqun Wu, Tao Wu and Dafang Chen
    Citation: Cardiovascular Diabetology 2022 21:276
    Content type: Research Published on:

  22. Migraine is one of the most common primary headache disorders and a well-known risk factor for cardiovascular disorders. We aimed to investigate the association between migraine and major cardiovascular outcom...

    Authors: Dae Young Cheon, Kyungdo Han, Ye Seul Yang, Yerim Kim, Sang-Hwa Lee, Chulho Kim, Jong-Hee Sohn, Mi Sun Oh, Byung-Chul Lee, Minwoo Lee and Kyung-Ho Yu
    Citation: Cardiovascular Diabetology 2022 21:275
    Content type: Research Published on:

  23. Results of cardiovascular outcome trials enabled a shift from “treat-to-target” to “treat-to-benefit” paradigm in the management of type 2 diabetes (T2D). However, studies validating such approach are limited....

    Authors: Mario Luca Morieri, Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Angelo Avogaro and Gian Paolo Fadini
    Citation: Cardiovascular Diabetology 2022 21:274
    Content type: Research Published on:

  24. Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) commonly coexist. However, NAFLD’s effect on mortality in Asian patients with type 2 diabetes awaits full elucidation. Therefore, we examined NAFLD...

    Authors: Goh Eun Chung, Su-Min Jeong, Eun Ju Cho, Ji Won Yoon, Jeong-Ju Yoo, Yuri Cho, Kyu-na Lee, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han and Su Jong Yu
    Citation: Cardiovascular Diabetology 2022 21:273
    Content type: Research Published on:

  25. Apolipoprotein C1 (apoC1) is a small size apolipoprotein whose exact role is not totally clarified but which seems to modulate significantly the metabolism of lipoproteins. ApoC1 is involved in the metabolism ...

    Authors: Alexia Rouland, David Masson, Laurent Lagrost, Bruno Vergès, Thomas Gautier and Benjamin Bouillet
    Citation: Cardiovascular Diabetology 2022 21:272
    Content type: Review Published on:

  26. Diabetes was commonly seen in chronic total occlusion (CTO) patients but data regarding the impact of successful percutaneous coronary intervention (PCI) on clinical outcome of CTO patients with diabetes was c...

    Authors: Shuai Zhao, Yan Chen, Qingyi Wang, Boda Zhu, Zhihong Wei, Ziwei Wang, Jiayi Wang, Yiming Zou, Wentao Hu, Cheng Liu, Tiantong Yu, Peng Han, Li Yang, Huan Wang, Chenhai Xia, Qiling Liu…
    Citation: Cardiovascular Diabetology 2022 21:271
    Content type: Research Published on:

  27. The newly proposed term “metabolic dysfunction-associated fatty liver disease” (MAFLD) is replacing the old term “non-alcoholic fatty liver disease” (NAFLD) in many global regions, because it better reflects t...

    Authors: Xiao-Dong Zhou, Jingjing Cai, Giovanni Targher, Christopher D. Byrne, Michael D. Shapiro, Ki-Chul Sung, Virend K. Somers, C. Anwar A. Chahal, Jacob George, Li-Li Chen, Yong Zhou and Ming-Hua Zheng
    Citation: Cardiovascular Diabetology 2022 21:270
    Content type: Review Published on:

  28. To evaluate the impact of different definitions of metabolic syndrome (MetS) and their components on the risk of sudden cardiac death (SCD) among the Iranian population according to the World Health Organizati...

    Authors: Soroush Masrouri, Seyyed Saeed Moazzeni, Neda Cheraghloo, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2022 21:269
    Content type: Research Published on:

  29. Recent studies have established that monocyte-derived inflammation plays a central role in the pathogenesis of type 2 diabetes mellitus (T2DM). It is unclear whether chronic metabolic inflammation, reflected b...

    Authors: Dan Wu, Yulong Lan, Yuancheng Xu, Songna Xu, Yuejun Huang, Lois Balmer, Gehendra Maharra, Wencan Xu, Wei Wang and Shouling Wu
    Citation: Cardiovascular Diabetology 2022 21:268
    Content type: Research Published on:

  30. We aimed to assess the gender-specific impact of 3-year changes in fasting plasma glucose (FPG) status on the risk of all-cause, cardiovascular (CV), and cancer mortality in individuals without type 2 diabetes...

    Authors: Karim Kohansal, Soroush Masrouri, Davood Khalili, Azra Ramezankhani, Fereidoun Azizi, Michael J Blaha and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2022 21:267
    Content type: Research Published on:

  31. An “obesity paradox” for mortality has been shown in chronic disorders such as diabetes, and attributed to methodological bias, including the use of body mass index (BMI) for obesity definition. This analysis ...

    Authors: Emanuela Orsi, Anna Solini, Giuseppe Penno, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Olga Lamacchia, Jonida Haxhi, Antonio Nicolucci and Giuseppe Pugliese
    Citation: Cardiovascular Diabetology 2022 21:266
    Content type: Research Published on:

  32. Dimethylarginine dimethylaminohydrolase (DDAH) 1 maintains the bioavailability of nitric oxide by degrading asymmetric dimethylarginine (ADMA). Here, we aimed to investigate the effect of haptoglobin (Hp) geno...

    Authors: Shiyun Wang, Zixuan Deng, Hong Zhang, Rong Zhang, Dandan Yan, Xiaojiao Zheng, Weiping Jia and Cheng Hu
    Citation: Cardiovascular Diabetology 2022 21:265
    Content type: Research Published on:

  33. Triglyceride-glucose (TyG) index has been proposed as a simple and credible surrogate for insulin resistance and an independent predictor of cardiovascular outcomes. Due to lack of data on TyG index in stroke,...

    Authors: Takao Hoshino, Takafumi Mizuno, Kentaro Ishizuka, Shuntaro Takahashi, Satoko Arai, Sono Toi and Kazuo Kitagawa
    Citation: Cardiovascular Diabetology 2022 21:264
    Content type: Research Published on:

  34. Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many re...

    Authors: Maciej Banach, Stanisław Surma, Zeljko Reiner, Niki Katsiki, Peter E. Penson, Zlatko Fras, Amirhossein Sahebkar, Francesco Paneni, Manfredi Rizzo and John Kastelein
    Citation: Cardiovascular Diabetology 2022 21:263
    Content type: Review Published on:

  35. Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glyce...

    Authors: Zhiyuan Wu, Siqi Yu, Haiping Zhang, Zheng Guo, Yulu Zheng, Zongkai Xu, Zhiwei Li, Xiangtong Liu, Xia Li, Shuo Chen, Jingbo Zhang, Lixin Tao and Xiuhua Guo
    Citation: Cardiovascular Diabetology 2022 21:262
    Content type: Research Published on:

  36. Enhanced de-novo collagen type VI (COL VI) formation has been associated with kidney and cardiovascular fibrosis. We hypothesized that endotrophin (ETP), a product specifically generated during collagen type V...

    Authors: Daniel Guldager Kring Rasmussen, Michael K. Hansen, Joseph Blair, Timothy A. Jatkoe, Bruce Neal, Morten A. Karsdal and Federica Genovese
    Citation: Cardiovascular Diabetology 2022 21:261
    Content type: Research Published on:

  37. The triglyceride glucose (TyG) index is an alternative to insulin resistance (IR) as an early indicator of worsening heart failure (HF). Patients with secondary mitral regurgitation (sMR) often experience prog...

    Authors: Haozhang Huang, Qiang Li, Jiulin Liu, Linfang Qiao, Shiqun Chen, Wenguang Lai, Yu Kang, Xiaozhao Lu, Yang Zhou, Yibo He, Jiyan Chen, Ning Tan, Jin Liu and Yong Liu
    Citation: Cardiovascular Diabetology 2022 21:260
    Content type: Research Published on:

  38. Coronary atherosclerosis can lead to serious cardiovascular events. In type 2 diabetes (T2DM) patients, the effects of clinical factors on coronary atherosclerosis have not been fully elucidated. We used a clu...

    Authors: Yu Jiang, Zhi-Gang Yang, Jin Wang, Rui Shi, Pei-Lun Han, Wen-Lei Qian, Wei-Feng Yan and Yuan Li
    Citation: Cardiovascular Diabetology 2022 21:259
    Content type: Research Published on:

  39. Diabetes and prediabetes are known risk factors for cardiovascular disease and associated with increased mortality risk. Whether patients with a random elevated blood glucose level but no history of diabetes a...

    Authors: Catarina Djupsjö, Jeanette Kuhl, Tomas Andersson, Magnus Lundbäck, Martin J. Holzmann and Thomas Nyström
    Citation: Cardiovascular Diabetology 2022 21:258
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2022 21:292

  40. Subjects with Type 1 diabetes mellitus (T1DM) have an increased incidence of heart failure (HF). Several pathophysiological mechanisms have been involved in its development. The aim of this study was to analyz...

    Authors: Carlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, M Teresa Julián, Núria Amigó, Henrik U Andersen, Tarunveer S Ahluwalia, Peter Rossing, Dídac Mauricio, Magnus T Jensen and Núria Alonso
    Citation: Cardiovascular Diabetology 2022 21:257
    Content type: Research Published on:

  41. The triglyceride–glucose (TyG) index is known as a reliable alternative marker of insulin resistance (IR), which has been regarded as a predictor of cardiovascular disease (CVD). However, whether TyG index can...

    Authors: Li Liu, Zhenguo Wu, Yifan Zhuang, Yerui Zhang, Huiliang Cui, Fanghong Lu, Jie Peng and Jianmin Yang
    Citation: Cardiovascular Diabetology 2022 21:256
    Content type: Research Published on:

  42. Individuals diagnosed with and treated for type 1 diabetes (T1D) have increased risk of micro- and macrovascular disease and excess mortality. Improving cardiovascular (CV) risk factors in individuals with T1D...

    Authors: Hanan Amadid, Kim Katrine Bjerring Clemmensen, Dorte Vistisen, Frederik Persson and Marit Eika Jørgensen
    Citation: Cardiovascular Diabetology 2022 21:255
    Content type: Research Published on:

  43. Evidence regarding thyroid-stimulating hormone (TSH) levels within the normal range and mortality in adults with diabetes is scarce. This study aimed to identify the association between TSH levels and cardiova...

    Authors: Ping Zhu, Guojuan Lao, Chuping Chen, Lihui Luo, Jing Gu and Jianmin Ran
    Citation: Cardiovascular Diabetology 2022 21:254
    Content type: Research Published on:

  44. Galectins are β-galactoside-binding proteins that bind and crosslink molecules via their sugar moieties, forming signaling and adhesion networks involved in cellular communication, differentiation, migration, ...

    Authors: Adel Abo Mansour, Franziska Krautter, Zhaogong Zhi, Asif Jilani Iqbal and Carlota Recio
    Citation: Cardiovascular Diabetology 2022 21:253
    Content type: Review Published on:

  45. Although type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) share many common pathological and physiological characteristics, there are few studies assessing the predictive capacity of novel bio...

    Authors: Yanhong Chen, Yu Fu, Shixin Wang, Pengsheng Chen, Yunfeng Pei, Jiao Zhang, Rui Zhang, Guoping Niu, Feng Gu and Xiaoli Li
    Citation: Cardiovascular Diabetology 2022 21:252
    Content type: Research Published on:

  46. It is unclear whether mental disorders are an independent risk factor for atrial fibrillation (AF) in patients with diabetes. We aimed to investigate whether patients with diabetes who have mental disorders ha...

    Authors: Nan Young Bae, So-Ryoung Lee, Eue-Keun Choi, Hyun Jin Ahn, Hyo-Jeong Ahn, Soonil Kwon, Kyung-Do Han, Kyu-Na Lee, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2022 21:251
    Content type: Research Published on:

  47. Triglyceride-glucose (TyG) index is a simple and reliable surrogate marker of insulin resistance. Elevated TyG index was related to stroke recurrence. This study aimed to explore the associations between TyG i...

    Authors: Li Wu, Jinmao Zhu, Chenghao Li, Juehua Zhu, Zheng Dai and Yongjun Jiang
    Citation: Cardiovascular Diabetology 2022 21:250
    Content type: Research Published on:

  48. Pleiotropic effects have been implicated in clinical benefits of ticagrelor compared to thienopyridine P2Y12 antagonists. There are conflicting data regarding effects of ticagrelor vs. thienopyridine P2Y12 blocke...

    Authors: Bernadeta Chyrchel, Olga Kruszelnicka and Andrzej Surdacki
    Citation: Cardiovascular Diabetology 2022 21:249
    Content type: Research Published on:

  49. The reno-protective effect of second-line treatments in type 2 diabetes has been assessed by clinical trials but generalizability to routine clinical practice is still uncertain. We aimed to assess the effecti...

    Authors: Sukanya Siriyotha, Thitiya Lukkunaprasit, Panu Looareesuwan, Hataikarn Nimitphong, Gareth J. McKay, John Attia and Ammarin Thakkinstian
    Citation: Cardiovascular Diabetology 2022 21:248
    Content type: Research Published on:

  50. Cardiovascular risk and body-weight management are both emerging challenges of type 1 diabetes care. We evaluated the association between intraindividual variability of body-weight and risk of cardiovascular e...

    Authors: Iulia Petria, Samuel Albuquerque, Gaël Varoquaux, Jill-Jênn Vie, Nicolas Venteclef, Kamel Mohammedi, Ronan Roussel, Marion Camoin, Gianluca Perseghin, Gilberto Velho and Louis Potier
    Citation: Cardiovascular Diabetology 2022 21:247
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840